“clinical-trial” Archives

Entry Author Date Location
Endomag, European Device Makers Eye U.S. Amid Regulatory Changes 10/20/16 Texas
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Heron Gains FDA Support For Nausea Drug After A Year Under Review 08/10/16 San Francisco
Texas Government Adds $3.5M to Fe3 Series B for Anemia Treatment 08/08/16 Texas
Metis Foundation, Targeting Military Researchers, Plans Fund Raise 08/05/16 Texas
Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure 07/18/16 San Diego
Xbiotech Responds to ESMO, Other Critics of Phase 3 Cancer Data 07/15/16 Texas
Second Genome Replaces DiLaura as CEO, Brings Series B to $51M 07/13/16 San Francisco
FDA Lets Juno Jump Back Into T-Cell Trial, Minus One Chemo Drug 07/12/16 Seattle
Caveats But No “Quicksand” In Sage’s Positive Postpartum Trial Data 07/12/16 Boston
With Positive Postpartum Results, Sage Ponders More Mood Disorders 07/12/16 Boston
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates 06/21/16 Texas
San Antonio Researchers Plan Trials for Drug Combo to Treat Ebola 06/03/16 Texas
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
A New Coat Makes The Difference in Rapamycin’s Disease Prevention 04/26/16 Texas
Spurned in Duchenne, BioMarin Will Seek Approval For Batten Drug 03/03/16 San Francisco
Austin Biotech Savara Nets $20M in Series C for Phase 3 Study 03/01/16 Texas
In Murky Regulatory Filings, Idaciti Seeks to Bring Transparency 02/17/16 Boulder/Denver
GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer 02/03/16 Texas
Armed With $30M, Akili Plans Bigger Trial of Therapeutic Video Game 01/22/16 Boston
With $100M, Guardant Health to Expand Reach of Blood Test for Cancer 01/07/16 San Francisco
Stemina, Eyeing Boston VC, Launches Large Autism Diagnostic Study 09/24/15 Wisconsin
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials 07/10/15 Boston
Green Park & Golf Brings Swedish Medtech “Cooling Cap” to Dallas 07/07/15 Texas
Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy 07/02/15 Boston
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers 06/30/15 Wisconsin
Page 1 of 2 next page »